DTRA’s Counter-WMD R&DE: $220M to ARA
Aug 31, 2011 16:48 EDT

The US Defense Threat Reduction Agency (DTRA) has a central role in addressing the threat of weapons of mass destruction (WMD). Their Research and Development Enterprise [PDF] is especially wide-ranging, covering everything from protective gear, to predictive and decision-support algorithms, to ScanEagle UAV variants that can monitor WMD levels, to co-operative non-proliferation programs, to development of new weapons like the Massive Ordnance Penetrator. Some of this work has even led to commercial spinoffs, vid. Sanofi Pasteur’s acquisition of VaxDesign and its DARPA/DTRA-financed MIMC model: an in vitro tool capable of predicting human immune response to specific bio-threat agents.
